Search
Avibactam tomilopil
go.drugbank.com/drugs/DB21560ExperimentalThe usage of the INN stem '-bactam' in the name indicates that Avibactam tomilopil is a ẞ-lactamase inhibitor. Avibactam tomilopil has a monoisotopic molecular weight of 393.12 Da.
Vonifimod
go.drugbank.com/drugs/DB21633ExperimentalThe usage of the INN stem '-imod' in the name indicates that Vonifimod is a immunomodulator, both stimulant/suppressive and stimulant. Vonifimod has a monoisotopic molecular weight of 326.27 Da.
Aneratrigine
go.drugbank.com/drugs/DB21639ExperimentalThe usage of the INN stem '-trigine' in the name indicates that Aneratrigine is a sodium channel blocker, signal transduction modulator. Aneratrigine has a monoisotopic molecular weight of 487.07 Da.
Resigratinib
go.drugbank.com/drugs/DB21664ExperimentalThe usage of the INN stem '-gratinib' in the name indicates that Resigratinib is a fibroblast growth factor receptor (FGFR) inhibitor. Resigratinib has a monoisotopic molecular weight of 523.21 Da.
Lirodegimod
go.drugbank.com/drugs/DB21675ExperimentalThe usage of the INN stem '-imod' in the name indicates that Lirodegimod is a immunomodulator, both stimulant/suppressive and stimulant. Lirodegimod has a monoisotopic molecular weight of 1256.45 Da.
Segatroxaban
go.drugbank.com/drugs/DB21678ExperimentalThe usage of the INN stem '-xaban' in the name indicates that Segatroxaban is a blood coagulation factor XA inhibitor, antithrombotic. Segatroxaban has a monoisotopic molecular weight of 567.14 Da.
Fanregratinib
go.drugbank.com/drugs/DB21688ExperimentalThe usage of the INN stem '-gratinib' in the name indicates that Fanregratinib is a fibroblast growth factor receptor (FGFR) inhibitor. Fanregratinib has a monoisotopic molecular weight of 508.24 Da.
Ilantimod
go.drugbank.com/drugs/DB21742ExperimentalThe usage of the INN stem '-imod' in the name indicates that Ilantimod is a immunomodulator, both stimulant/suppressive and stimulant. Ilantimod has a monoisotopic molecular weight of 387.11 Da.
Allisartan isoproxil
go.drugbank.com/drugs/DB18880InvestigationalAllisartan isoproxil is under investigation in clinical trial NCT03264352 (Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes).
Categories: Agents Acting on the Renin-Angiotensin SystemIproclozide
go.drugbank.com/drugs/DB09247ApprovedWithdrawnfatalities has resulted ultimately in the agent being discontinued. … Iproclozide is an irreversible and selective hydrazine class based monoamine oxidase inhibitor (MAOI).